Study of Safety and Efficacy of Multiple Doses of CFZ533 in Two Distinct Populations of Patients With Sjogren's Syndrome

ישראלהושלםPHASE2

מצבים רפואיים

Sjögren Syndrome

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • North GA Rheumatology Group PC, Suwanee, Georgia, United States

  • Indiana Univ School of Dentistry, Indianapolis, Indiana, United States

  • Ochsner Health System, Baton Rouge, Louisiana, United States

  • The John Hopkins Jerome L Greene Sjogren, Baltimore, Maryland, United States

  • Tufts School of Dental Medicine, Boston, Massachusetts, United States

  • Winthrop University Hospital, Mineola, New York, United States

  • Perelman School of Medicine, Philadelphia, Pennsylvania, United States

  • Uni Wisconsin School Med Pub Health, Madison, Wisconsin, United States

  • Novartis Investigative Site, Buenos Aires, Argentina

  • Novartis Investigative Site, CABA, Argentina

  • Novartis Investigative Site, Nedlands, Western Australia, Australia

  • Novartis Investigative Site, Graz, Austria

  • Novartis Investigative Site, Vienna, Austria

  • Novartis Investigative Site, Vitória, Espírito Santo, Brazil

  • Novartis Investigative Site, Juiz de Fora, Minas Gerais, Brazil

  • Novartis Investigative Site, São Paulo, São Paulo, Brazil

  • Novartis Investigative Site, Toronto, Ontario, Canada

  • Novartis Investigative Site, Rimouski, Quebec, Canada

  • Novartis Investigative Site, Trois-Rivières, Quebec, Canada

  • Novartis Investigative Site, Valdivia, Los Ríos Region, Chile

  • Novartis Investigative Site, Santiago, RM, Chile

  • Novartis Investigative Site, Santiago, Santiago Metropolitan, Chile

  • Novartis Investigative Site, Santiago, Santiago Metropolitan, Chile

  • Novartis Investigative Site, Concepción, Chile

  • Novartis Investigative Site, Medellín, Antioquia, Colombia

  • Novartis Investigative Site, Barranquilla, Atlántico, Colombia

  • Novartis Investigative Site, Cali, Valle del Cauca Department, Colombia

  • Novartis Investigative Site, Brest, France

  • Novartis Investigative Site, Le Kremlin-Bicêtre, France

  • Novartis Investigative Site, Lille, France

  • Novartis Investigative Site, Paris, France

  • Novartis Investigative Site, Strasbourg, France

  • Novartis Investigative Site, Freiburg im Breisgau, Baden-Wurttemberg, Germany

  • Novartis Investigative Site, Würzburg, Bavaria, Germany

  • Novartis Investigative Site, Dresden, Saxony, Germany

  • Novartis Investigative Site, Bonn, Germany

  • Novartis Investigative Site, Athens, Greece

  • Novartis Investigative Site, Székesfehérvár, Fejér, Hungary

  • Novartis Investigative Site, Budapest, Hungary

  • Novartis Investigative Site, Szeged, Hungary

  • Novartis Investigative Site, Haifa, Israel

  • Novartis Investigative Site, Kfar Saba, Israel

  • Novartis Investigative Site, Ramat Gan, Israel

  • Novartis Investigative Site, Milan, MI, Italy

  • Novartis Investigative Site, Pisa, PI, Italy

  • Novartis Investigative Site, Udine, UD, Italy

  • Novartis Investigative Site, Nagoya, Aichi-ken, Japan

  • Novartis Investigative Site, Sasebo, Nagasaki, Japan

  • Novartis Investigative Site, Kurashiki, Okayama-ken, Japan

  • Novartis Investigative Site, Chuo Ku, Tokyo, Japan

  • Novartis Investigative Site, Shinjuku-ku, Tokyo, Japan

  • Novartis Investigative Site, Rotterdam, South Holland, Netherlands

  • Novartis Investigative Site, Groningen, Netherlands

  • Novartis Investigative Site, Almada, Portugal

  • Novartis Investigative Site, Lisbon, Portugal

  • Novartis Investigative Site, Lisbon, Portugal

  • Novartis Investigative Site, Ponte de Lima, Portugal

  • Novartis Investigative Site, Brasov, Romania

  • Novartis Investigative Site, Cluj-Napoca, Romania

  • Novartis Investigative Site, Kazan', Russia

  • Novartis Investigative Site, Moscow, Russia

  • Novartis Investigative Site, Orenburg, Russia

  • Novartis Investigative Site, Saint Petersburg, Russia

  • Novartis Investigative Site, Tomsk, Russia

  • Novartis Investigative Site, Yekaterinburg, Russia

  • Novartis Investigative Site, Seoul, Seocho Gu, South Korea

  • Novartis Investigative Site, Stockholm, SE, Sweden

  • Novartis Investigative Site, Ankara, Yenimahalle, Turkey (Türkiye)

  • Novartis Investigative Site, Birmingham, United Kingdom

  • Novartis Investigative Site, Doncaster, United Kingdom

  • Novartis Investigative Site, Manchester, United Kingdom

מובילי המחקר
  • Study Director Novartis Pharmaceuticals

    Study Director

    Novartis Pharmaceuticals